stoxline Quote Chart Rank Option Currency Glossary
  
Inspira Technologies Oxy B.H.N. Ltd. (IINN)
1.95  -0.06 (-2.99%)    06-13 16:00
Open: 2.01
High: 2.01
Volume: 110,740
  
Pre. Close: 2.01
Low: 1.89
Market Cap: 34(M)
Technical analysis
2024-06-13 4:44:07 PM
Short term     
Mid term     
Targets 6-month :  2.56 1-year :  2.86
Resists First :  2.19 Second :  2.45
Pivot price 2.11
Supports First :  1.77 Second :  1.48
MAs MA(5) :  2.01 MA(20) :  2.14
MA(100) :  1.73 MA(250) :  1.46
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  31.3 D(3) :  34.6
RSI RSI(14): 41.5
52-week High :  2.49 Low :  0.76
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ IINN ] has closed above bottom band by 11.8%. Bollinger Bands are 6.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.01 - 2.02 2.02 - 2.03
Low: 1.86 - 1.87 1.87 - 1.89
Close: 1.93 - 1.95 1.95 - 1.97
Company Description

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Headline News

Thu, 13 Jun 2024
Inspira secures first purchase order for ART100 systems By Investing.com - Investing.com

Thu, 13 Jun 2024
Inspira Technologies receives first purchase order for INSPIRA ART100 systems - Seeking Alpha

Thu, 13 Jun 2024
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S. - PR Newswire

Sun, 09 Jun 2024
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) & OrthoPediatrics (NASDAQ:KIDS) Financial Comparison - Defense World

Wed, 05 Jun 2024
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector - Morningstar

Thu, 30 May 2024
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant ... - Morningstar

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 17 (M)
Shares Float 10 (M)
Held by Insiders 9.4 (%)
Held by Institutions 0.5 (%)
Shares Short 134 (K)
Shares Short P.Month 230 (K)
Stock Financials
EPS -0.94
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.37
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -59.6 %
Return on Equity (ttm) -116.6 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.7
Qtrly Earnings Growth 0 %
Operating Cash Flow -10 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -2.1
PEG Ratio 0
Price to Book value 5.27
Price to Sales 0
Price to Cash Flow -3.48
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android